Title : Olaparib and rucaparib for the treatment of DNA repair-deficient metastatic castration-resistant prostate cancer.

Pub. Date : 2021 Aug

PMID : 33827356






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We also recommend that olaparib or rucaparib be considered relatively early in the treatment sequence in metastatic castration-resistant prostate cancer patients with BRCA1 or BRCA2 mutations. rucaparib BRCA1 DNA repair associated Homo sapiens